Cooking your meals and snacks gives you more control over your diet
In both cases, I am finding the optimal pharmacologic dose for ongoing treatment
Concerns about the potential association between certain diabetes medications and cardiovascular disease meant that in 2010 the FDA approved liraglutide on condition that Novo Nordisk conduct a post-marketing study to evaluate the drug's effect on the incidence of major cardiovascular events (Nielsen, DeChiaro, Goldman)
Side effects were more common in the oral semaglutide group (16.7%) than in the injection group (4.9%)
Services available through the clinic include: medical weight management supportGLP-1 treatment optionsnutrition counseling and coaching programsmetabolic testing and body composition analysis3D body scanning assessments Some individuals may also explore supportive services such as muscle-building and toning programs or non-invasive body contouring treatments as part of broader wellness planning
While this is a single case report and not necessarily generalizable, it underscores why thyroid monitoring during GLP-1 therapy is not optional, it is essential
